George Saviolakis is an Endocrinology/Metabolic physician affiliated with General Dynamics. OpenAlex indexes 44 publications with 1,085 citations (h-index 18); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4301 Jones Bridge Rd
Usuhs Clinical Pharmacology, Bldg 53, Room 109
Bethesda, MD 208144712
Telephone
301-295-6434Registry record last updated 11 Sept 2025.
Clinical trials
- Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B
Sponsor: DynPort Vaccine Company LLC, A GDIT Company
- Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant
Sponsor: DynPort Vaccine Company LLC, A GDIT Company
- Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Sponsor: DynPort Vaccine Company LLC, A GDIT Company
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 2015–2025 per NIH RePORTER. The latest:
- Task A: Early Phase Clinical Trial Units (EPCTU)
Dynport Vaccine Company, Llc
FY2025$215,60475N93022D00016 - Task A: Early Phase Clinical Trial Units (EPCTU)
Dynport Vaccine Company, Llc
FY2024$212,10575N93022D00016
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus
The Journal of Infectious Diseases
2021 - Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers
Clinical Pharmacology in Drug Development
2020
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”